Neoadjuvant Chemotherapy With or Without Metformin in Early Breast Cancer.

  • STATUS
    Recruiting
  • participants needed
    120
  • sponsor
    Mansoura University
Updated on 19 February 2024
cancer
breast cancer
metastasis
breast carcinoma
carcinoma
metformin
preoperative chemotherapy

Summary

Metformin is a widely used anti-diabetic drug. Several studies have pointed out a potentially beneficial effect of metformin therapy in diabetic cancer patients. Several studies are investigating the anti-tumor effect of metformin in early breast cancer. However, the enhancing effect of metformin on anti-tumor immunity has only been demonstrated in animal models. This study examines the immune effect of metformin in breast cancer patients treated with preoperative chemotherapy.

Details
Condition Breast Cancer, Breast Cancer
Age 18-65 years
Treatment Placebo Oral Tablet, Metformin
Clinical Study IdentifierNCT04387630
SponsorMansoura University
Last Modified on19 February 2024

Eligibility

Yes No Not Sure

Inclusion Criteria

Histologically proven breast carcinoma
American Society of Anesthesiology (ASA) score I-II
Candidate for neoadjuvant chemotherapy as per hospital's protocol
Clinically measurable tumor
No evidence of distant metastasis
Normal renal and liver functions
Non-diabetics

Exclusion Criteria

Pregnant or lactating women
Metastatic breast cancer patients
Patients with hepatic impairment
Patients with renal impairment
Diabetics
Patients unwilling to participate or withdrawing from the trial
Psychological/ mental impairment
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.